Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Targeting Phosphatidylserine with Calcium-Dependent Protein-Drug Conjugates for the Treatment of Cancer.

Li R, Chiguru S, Li L, Kim D, Velmurugan R, Kim D, Devanaboyina SC, Tian H, Schroit A, Mason RP, Ober RJ, Ward ES.

Mol Cancer Ther. 2018 Jan;17(1):169-182. doi: 10.1158/1535-7163.MCT-17-0092. Epub 2017 Sep 22.

PMID:
28939556
2.

Use of Fc-Engineered Antibodies as Clearing Agents to Increase Contrast During PET.

Swiercz R, Chiguru S, Tahmasbi A, Ramezani SM, Hao G, Challa DK, Lewis MA, Kulkarni PV, Sun X, Ober RJ, Mason RP, Ward ES.

J Nucl Med. 2014 Jul;55(7):1204-7. doi: 10.2967/jnumed.113.136481. Epub 2014 May 27.

3.

New frontiers and developing applications in 19F NMR.

Yu JX, Hallac RR, Chiguru S, Mason RP.

Prog Nucl Magn Reson Spectrosc. 2013 Apr;70:25-49. doi: 10.1016/j.pnmrs.2012.10.001. Epub 2012 Nov 2. Review. No abstract available.

Supplemental Content

Loading ...
Support Center